Document Detail


Transcatheter patent foramen ovale closure in spite of interatrial septum hypertrophy or lipomatosis: a case series.
MedLine Citation:
PMID:  19829139     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Hypertrophy and lipomatosis of the interatrial septum have been thought to be contraindications for transcatheter patent foramen ovale (PFO) and atrial septal defect closure because of the limits of current devices and the risk of suboptimal results. No reports have been produced yet about PFO closure in patients with such conditions. We retrospectively assessed the safety and effectiveness of PFO closure in patients with hypertrophy or lipomatosis of fossa ovalis rims. METHODS: We searched our database of 140 consecutive patients (mean age 43 +/- 15. 5 years, 98 female patients) who underwent transcatheter PFO closure for cases of hypertrophy or lipomatosis of the interatrial septum. All patients were screened with transesophageal echocardiography before the operation. All patients underwent intracardiac echocardiography study and attempted closure. RESULTS: Ten patients (7.1%) underwent an attempt at transcatheter closure in the presence of hypertrophy of the rims (eight patients) or lipomatosis (two patients). All patients were aged more than 50 years and has multiple recurrent stroke events (nine patients) or need for a posterior cerebral surgical procedure (one patient) making closure mandatory. After intracardiac echocardiography study and measurements, two 25 mm Amplatzer and eight 25 mm Premere Occlusion System devices have been implanted successfully. On mean follow-up of 36.6 +/- 14.8 months, two patients had a small residual shunt: no recurrence of stroke or aortic erosion or device thrombosis was observed during this period. CONCLUSION: Transcatheter PFO closure in the presence of hypertrophy or lipomatosis of fossa ovalis rims is not contraindicated per se: careful evaluation of rim thickness with intracardiac echocardiography and selection of soft and asymmetrically opening devices may allow for a safe and effective PFO closure, at least in patients with no severe atrial septal aneurysm.
Authors:
Gianluca Rigatelli; Fabio Dell'Avvocata; Massimo Giordan; Federico Ronco; Gabriele Braggion; Nella Schenal; Silvio Aggio; Paolo Cardaioli
Related Documents :
8256739 - Long-term follow-up (9 to 20 years) after surgical closure of atrial septal defect at a...
402389 - Gray scale measurement of biparietal diameter.
17073989 - Combination of pulse therapy with terbinafine tablets and topical terbinafine cream for...
16222889 - Endothelial dysfunction, distensibility and intima-media thickness and aetiology of str...
8772759 - Effects of oral propafenone administration before electrical cardioversion of chronic a...
1539519 - Pharmacologic suppression of atrial flutter induced by atrial stimulation.
10533019 - Rapid reversal of life-threatening diltiazem-induced tetany with calcium chloride.
12322819 - Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritonea...
20456059 - Gastric contents in pediatric patients following bone marrow transplantation.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cardiovascular medicine (Hagerstown, Md.)     Volume:  11     ISSN:  1558-2035     ISO Abbreviation:  J Cardiovasc Med (Hagerstown)     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2009-12-25     Completed Date:  2010-03-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101259752     Medline TA:  J Cardiovasc Med (Hagerstown)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  91-5     Citation Subset:  IM    
Affiliation:
Section of Adult Congenital and Adult Heart Disease, Cardiovascular Diagnosis and Endoluminal Interventions, Rovigo General Hospital, Rovigo, Italy. jackyheart@libero.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Echocardiography
Female
Foramen Ovale, Patent / complications,  pathology,  therapy*
Heart Catheterization*
Heart Septum / pathology
Humans
Hypertrophy
Lipomatosis / complications*
Male
Middle Aged
Retrospective Studies

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Myocardial infarction in a young patient with a previous history of repeated thrombophlebitis: combi...
Next Document:  A new way of targeting to treat coronary artery disease.